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Application of Framingham risk estimates to ethnic
minorities in United Kingdom and implications for
primary prevention of heart disease in general practice:
cross sectional population based study
Francesco P Cappuccio, Pippa Oakeshott, Pasquale Strazzullo, Sally M Kerry
Abstract
Objective To compare the 10 year risk of coronary
heart disease (CHD), stroke, and combined
cardiovascular disease (CVD) estimated from the
Framingham equations.
Design Population based cross sectional survey.
Setting Nine general practices in south London.
Population 1386 men and women, age 40›59 years,
with no history of CVD (475 white people, 447 south
Asian people, and 464 people of African origin), and
a subgroup of 1069 without known diabetes, left
ventricular hypertrophy, peripheral vascular disease,
renal impairment, or target organ damage.
Main outcome measures 10 year risk estimates.
Results People of African origin had the lowest 10
year risk estimate of CHD adjusted for age and sex
(7.0%, 95% confidence interval 6.5 to 7.5) compared
with white people (8.8%, 8.2 to 9.5) and south Asians
(9.2%, 8.6 to 9.9) and the highest estimated risk of
stroke (1.7% (1.5 to 1.9), 1.4% (1.3 to 1.6), 1.6% (1.5 to
1.8), respectively). The estimate risk of combined
CVD, however, was highest in south Asians (12.5%,
11.6 to 13.4) compared with white people (11.9%,
11.0 to 12.7) and people of African origin (10.5%, 9.7
to 11.2). In the subgroup of 1069, the probability that
a risk of CHD >15% would identify risk of combined
CVD >20% was 91% in white people and 81% in
both south Asians and people of African origin. The
use of thresholds for risk of CHD of 12% in south
Asians and 10% in people of African origin would
increase the probability of identifying those at risk to
100% and 97%, respectively.
Conclusion Primary care doctors should use a lower
threshold of CHD risk when treating mild
uncomplicated hypertension in people of African or
south Asian origin.
Introduction
The prevention of coronary heart disease (CHD) and
cardiovascular disease (CVD) now relies on the reduc›
tion of the overall absolute risk of disease rather than
management of individual risk factors.1 The strategy
for primary prevention in people with no history of
CVD is to estimate the absolute risk of a vascular event
and to take appropriate action according to that level
of risk.2–4 British hypertension guidelines suggest that
people with moderate blood pressure (140›159/90›99
mm Hg) but no target organ damage, cardiovascular
complications, or diabetes should be treated if their 10
year risk of CHD (myocardial infarction, death from
other CHD, angina, and coronary insufficiency) is
>15%.3 This assumes that the risk of combined CVD
(risk of CHD plus stroke, transient ischaemic attack,
congestive cardiac failure, and peripheral vascular dis›
ease) may be obtained by multiplying the estimated 10
year risk of CHD by 4/3 (for example, 15% risk of
CHD=20% risk of CVD).5 The risk estimation is based
on the 10 year prospective experience of the Framing›
ham cohort, white middle class men and women, aged
30›74 years, living in semiurban Massachusetts.
Compared with white people, people of African origin
have less CHD but more hypertension, diabetes,
strokes, and renal failure, and south Asians have more
hypertension, diabetes, central obesity, and CHD.6 7
The estimate of risk with the Framingham equation
may not accurately estimate the risk of vascular disease
in some ethnic minorities.2 3 In addition, the equiva›
lence between the risk of CHD and the risk of CVD
may not apply. Given the lack of prospective data in
large ethnically mixed populations in the United King›
dom, however, these risk equations are the best
available tools to guide the decision making process of
prevention in general practice. However, we do not
know what impact this approach may have on the
management of hypertension in selected ethnic
groups. We compared the estimated risks of CHD,
stroke, and combined CVD in a general practice
sample of white people, south Asians, and people of
African origin from south London and looked at the
implications of using these risk estimates.
Methods
The survey methods are described in detail else›
where.7 8 Briefly, we recruited men and women aged
40›59 years from nine general practices in Wands›
worth, south London, where about a quarter of the
residents are from ethnic minorities. Participants likely
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to be of south Asian or west African origin were identi›
fied by family name, while Afro›Caribbeans were iden›
tified by general practitioners and receptionists. We
also invited a random sample of white patients to yield
an equal number of participants in each ethnic group.
The study protocol was approved by the local ethics
committee, and all participants gave informed consent.
Fieldwork was undertaken from March 1994 to July
1996. Ethnic group was recorded at the time of
interview on the basis of answers to a combination of
questions including place and country of birth,
language, religion, history of migration, and parents’
country of birth.7 8
The overall response rate to invitations was 64%.8
Of the 1577 participants screened, we excluded 119
because of missing values for any of the risk factors
used in the Framingham equations and 72 because of
pre›existing CHD or stroke. This left 1386 participants
(475 white people, 447 south Asian, and 464 of African
origin). There were 760 (55%) women.
After an overnight fast participants attended a
dedicated screening unit between 8 am and noon.
Blood pressure was taken with standardised meth›
ods.7 8 Participants not known to be diabetic and with›
out glycosuria underwent a standard oral glucose
tolerance test.7 8 Blood samples were taken for full lipid
profile. Participants were classified as smokers if they
were currently smoking one or more cigarettes, cigars,
or pipes on a regular daily basis. Diabetes was defined
according to both the new American Diabetes Associ›
ation9 10 and World Health Organization criteria.7 8 A
12 lead electrocardiogram (ECG) was used to detect
left ventricular hypertrophy according to Minnesota
coding.11 Although this may overestimate left ventricu›
lar mass in people of African origin compared with
white people,12 it is the method routinely used in gen›
eral practice. Peripheral vascular disease was coded
from the answers to the Edinburgh questionnaire,13
and renal impairment was defined as serum creatinine
concentration > 160 ìmol/l. No participant had
evidence of fundal exudates, haemorrhages, or
papilloedema. In line with the guidelines,3 for
subsequent analyses on treatment thresholds we
excluded 317 participants with previously known
diabetes (n=103), left ventricular hypertrophy on ECG
(n=103), peripheral vascular disease (n=91), renal
impairment (n=2), or other clinical target organ
damage (n=18). This left 1069 participants for analysis
(404 white people, 342 south Asian, and 323 of African
origin).
We compared categorical variables between each
ethnic group using age standardisation with the direct
method. We used five year age bands with equal num›
bers in each band. We used analysis of covariance to
adjust blood pressure and cholesterol concentration
for age and compare between ethnic groups for
baseline analysis. The three groups were compared
with a global F test. We log transformed high density
lipoprotein cholesterol concentration and the ratio of
total to high density lipoprotein cholesterol before
analysis of covariance and report geometric means for
ease of reference to absolute values.
We used published equations for predicting the
incident risk of CHD, stroke, and combined CVD from
the Framingham study to calculate each participant’s
10 year risk of a first event, fatal or not fatal (see box).14
The independent variables included in the
equation were age, sex, systolic blood pressure,
total:high density lipoprotein cholesterol, smoking,
and diabetes (American Diabetes Association defini›
tion). Blood pressure was considered irrespective of
whether or not participants were on antihypertensive
treatment.15
We compared risk between each ethnic group by
analysis of variance, weighting each observation by the
inverse of the number of patients in each age›sex›
ethnicity group, thereby adjusting for age and sex,
using five year age bands. We estimated the
associations between risk of CVD and CHD in different
ethnic groups by regression analysis and calculated
confidence intervals for the regression coefficients
using the bootstrap method. The sensitivity of the esti›
mated risk of CHD to predict the risk of CVD in
people with no cardiovascular complications was
calculated in each ethnic group and for different
thresholds of risk of CHD.16 The population attribut›
able risk for high blood pressure was estimated by
replacing in the Framingham equations all systolic
blood pressures > 140 mm Hg with 139 mm Hg (that
is, we assumed that treatment would result in a systolic
blood pressure < 140 mm Hg). We calculated the aver›
age reduction in risk for all participants in each ethnic
group.16 This is a conservative estimate of the number
of cardiovascular events (per 1000 population per
year) that would be prevented if all participants with a
Framingham equations for 10 year risk of event
Equation 1: where âi and xi are defined in table 1.
Different values of âi are used for CHD, stroke, and CVD
Equation 2: ó=è0+ìè1 where è0 and è1 are defined in table 2 and ì is defined
from equation 1
Equation 3: ì is defined in equation 1 and ó is defined in
equation 2; for other time periods ln(10) can be replaced with the number
of years
Equation 4: 10 year risk of event = where u is defined in equation 3
Table 1 Coefficients for independent variables in Framingham equations
i xi
Coefficients âi
CHD Stroke CVD
1 Female=1, male=0 28.4441 0.2019 −1.2146
2 Ln age (years) −1.4792 −2.3741 −1.8443
3 (Ln age (years))2 0 0 0
4 Ln (age) if female, 0 if male −14.4588 0 0.3668
5 (Ln age)2 if female, 0 if male 1.8515 0 0
6 Ln systolic blood pressure −0.9119 −2.4643 −1.4032
7 Current smoker=1, 0 otherwise −0.2767 −0.3914 −0.3899
8 Ln (total cholesterol)/(HDL) −0.7181 −0.0229 −0.5390
9 Diabetic=1, non›diabetic=0 −0.1759 −0.3087 −0.3036
10 Female and diabetic=1, 0 otherwise −0.1999 −0.2627 −0.1697
CHD=coronary heart disease, CVD=cardiovascular disease, HDL=high density lipoprotein cholesterol.
Table 2 Other constants used in equations
CHD Stroke Coefficients for CVD
è0 0.9145 −0.4312 0.6536
è1 −0.2784 0 −0.2402
â0 15.5305 26.5116 18.8144
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systolic blood pressure above target were successfully
treated and their blood pressure was reduced to < 140
mm Hg because in some patients systolic blood
pressure would be reduced to lower than 139 mm Hg.
The analysis was carried out using Stata 6.0 and SPSS
10.0.
Results
Table 3 gives details of participants. People of African
origin had higher blood pressure and higher
concentrations of high density lipoprotein cholesterol
compared with the other ethnic groups. Diabetes
(using both classifications) was more common among
ethnic minority groups, and smoking was more
common among white people.
The estimated 10 year risk of CHD adjusted for age
and sex, varied significantly by ethnic group (table 4).
South Asians had the greatest risk of CHD and
combined CVD, whereas people of African origin had
the lowest. However, people of African origin had the
highest risk of stroke.
Estimates for risk of CHD and CVD showed a high
degree of correlation in each ethnic group (r=0.97,
0.96, 0.96 in white people, south Asians, and people of
African origin, respectively). However, the slope of the
regression line of risk of CVD against risk of CHD was
steeper in people of African origin and south Asians
than in white people (fig 1). This indicates that for a
given 10 year risk of CHD the estimated risk of
combined CVD is higher in people of African and
south Asian origin than in white people.
After we excluded those with known diabetes, left
ventricular hypertrophy, periphreal vascular disease,
renal impairment, and other organ damage, the prob›
ability of having a risk of CVD>20% if the risk of CHD
is >15% (that is, sensitivity) was higher in white people
(50/55 (91%)) than in south Asians (30/37 (81%)) and
people of African origin (26/32 (81%)). However, a risk
of CHD >12% would identify 100% of south Asians,
and a risk of CHD>10% would identify 97% of people
of African origin with a risk of CVD >20% (fig 2). If
these new thresholds were used, about 8% of south
Asians and 11% of people of African origin with mild
hypertension whose risk of CVD was < 20% would
also receive treatment.
The proportion of participants with blood pressure
above the National Service Framework target of
140/85 mm Hg4 was highest among people of African
origin (274/464 (59%, 55% to 64%)), intermediate in
south Asians (193/447 (43%, 39% to 48%)), and lowest
in whites (155/475 (33%, 28% to 37%)), even though
the group of people of African origin had the highest
proportion of treated individuals (30% v 12% south
Table 3 Age adjusted means (95% confidence interval) of variables used in Framingham equation to estimate 10 year risk of coronary
heart disease, stroke, and combined cardiovascular disease
Variables White South Asian African origin
Men
No of men 215 227 184
Age (years)* 50.4 (49.6 to 51.1) 49.2 (48.4 to 49.9) 51.6 (50.8 to 52.4)
Systolic blood pressure (mm Hg) 127 (125 to 130) 131 (128 to 133) 133 (130 to 136)
Diastolic blood pressure (mm Hg) 82 (80 to 83) 86 (84 to 87) 87 (86 to 89)
Total cholesterol (mmol/l) 6.2 (6.1 to 6.4) 5.7 (5.6 to 5.9) 5.4 (5.3 to 5.6)
HDL cholesterol (mmol/l)† 1.22 (1.18 to 1.26) 1.05 (1.02 to 1.09) 1.30 (1.26 to 1.35)
Total:HDL cholesterol† 5.0 (4.8 to 5.2) 5.3 (5.1 to 5.5) 4.1 (3.9 to 4.3)
Current smoking (%) 40 (33 to 46) 26 (20 to 32) 18 (12 to 24)
Diabetes by WHO (%) 6 (2 to 9) 24 (18 to 30) 16 (10 to 22)
Diabetes by ADA (%) 3 (1 to 5) 20 (15 to 25) 16 (10 to 21)
Women
No of women 260 220 280
Age (years)* 49.1 (48.4 to 49.8) 48.7 (47.9 to 49.4) 50.2 (49.5 to 50.8)
Systolic blood pressure (mm Hg) 124 (121 to 126) 128 (126 to 130) 133 (131 to 136)
Diastolic blood pressure (mm Hg) 77 (76 to 78) 80 (79 to 81) 85 (84 to 86)
Total cholesterol (mmol/l) 6.2 (6.1 to 6.4) 5.7 (5.6 to 5.8) 5.7 (5.6 to 5.8)
HDL cholesterol (mmol/l)† 1.47 (1.42 to 1.52) 1.28 (1.23 to 1.32) 1.54 (1.50 to 1.59)
Total:HDL cholesterol† 4.2 (4.0 to 4.3) 4.4 (4.2 to 4.5) 3.6 (3.5 to 3.7)
Current smoking (%) 33 (27 to 39) 3 (1 to 5) 8 (5 to 12)
Diabetes by WHO (%) 5 (2 to 8) 18 (13 to 24) 13 (8 to 17)
Diabetes by ADA (%) 3 (1 to 6) 12 (8 to 16) 9 (5 to 12)
HDL=high density lipoprotein; WHO=World Health Organization; ADA=American Diabetes Association.
*Not adjusted.
†Geometric means.
Table 4 Age and sex adjusted 10 year risk* of coronary heart disease (CHD), stroke, and cardiovascular disease (CVD) in each ethnic
group as estimated by Framingham equations. Figures are means (95% confidence interval)
White (n=475) South Asian (n=447) African origin (n=464) P value†
CHD‡ 8.8 (8.2 to 9.5) 9.2 (8.6 to 9.9) 7.0 (6.5 to 7.5) <0.001
Stroke 1.4 (1.3 to 1.6) 1.6 (1.5 to 1.8) 1.7 (1.5 to 1.9) 0.036
CVD§ 11.9 (11.0 to 12.7) 12.5 (11.6 to 13.4) 10.5 (9.7 to 11.2) 0.003
*Equivalent to incidence rate per 1000 per year.
†For heterogeneity.
‡Includes myocardial infarction, CHD death, angina, and coronary insufficiency.
§Includes CHD plus stroke, transient ischaemic attack, congestive cardiac failure, and peripheral vascular disease.
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Asians and 8% white people). The population risks for
CHD, stroke, and CVD attributable to systolic blood
pressure above target were higher in people of African
origin—and to a lesser extent in south Asians—than in
white people. For CVD they were 1.11 (0.88 to 1.34),
0.92 (0.68 to 1.15), and 0.67 (0.49 to 0.85) per 1000
population per year, respectively. These differences
suggest that adequate treatment of high blood pressure
might prevent a proportionally greater number of
cardiovascular events in people of African origin and
in south Asians than in white people.
Discussion
This is the first study based in general practice to show
that the use of risk of CHD in south Asians and people
of African origin underestimates their risk of CVD.
This implies that we should be using different
thresholds—such as, 12% and 10%, respectively—to
manage the same overall vascular risk. The associations
between risks of CHD and CVD are different between
groups so that the use of an estimate of risk of CHD
>15% in primary care may result in undertreatment of
mild hypertension in south Asians and in people of
African origin with a risk of CVD of >20%. Although
more people of African origin were receiving
treatment, they also had the highest prevalence of
blood pressure above target. Therefore, in people of
African origin the population risk attributable to blood
pressure above target was higher and the potential
benefits of adequate management greater.
Strengths and weaknesses
Our participants were from a community population
and were being cared for in primary care. Our results
are relevant to general practice, where most primary
prevention of CHD and management of people with
hypertension takes place. All measurements of risk fac›
tors were done according to a strict protocol.7 8 Finally
the fact that the study was population based avoided
the “healthy worker” effect.
The application of risk equations to ethnic groups
is based on the assumption that the effect of each risk
factor is constant across groups as prospective data on
British ethnic minority cohorts are lacking. The differ›
ences in estimated risks therefore depend on the level
or prevalence of the risk factor. This seems realistic as
we have no evidence to suggest that management of
risk factors may have differential benefit according to
ethnic origin. The study was relatively small and may
lack statistical power, particularly where estimates of
risk are small, as in stroke. Furthermore, the analysis
was restricted to men and women aged 40›59 years,
and results may therefore apply only to this age group.
We did not take into account family history of prema›
ture CHD,2 and we considered blood pressure
irrespective of treatment. All these factors will tend to
underestimate our calculations of risk. We recorded
blood pressure as the average of two measurements
taken on a single occasion. National guidelines recom›
mend that blood pressure is considered after repeated
Fig 1 Association between risk of coronary heart disease (CHD) and
risk of combined cardiovascular disease (CVD) in white people
(n=475), south Asians (n=447), and people of African origin (n=464)
with no evidence of ischaemic heart disease or stroke. Slopes of
regression lines are 1.30 (1.27 to 1.34), 1.40 (1.35 to 1.45), and
1.48 (1.40 to 1.55) % increase in risk of CVD per % risk of CHD,
respectively; P<0.001
Fig 2 Sensitivity and specificity of thresholds for 10 year risk of
CHD to identify 10 year risk of CVD >20% in each ethnic group
after exclusion of people with known diabetes, left ventricular
hypertrophy, peripheral vascular disease, renal impairment, or other
clinical target organ damage
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measurements.3 5 This may have led to overestimates,
thereby overstating risk because in clinical practice
drug treatment is not usually started without at least
two repeated measurements on different occasions.
This would allow for adaptation and lower average
blood pressure. However, if this effect was evenly
distributed across measurements it should not have
biased our results in either direction.
Comparison with other studies
The Framingham coronary heart disease prediction
scores have recently been validated in American
cohorts of different ethnic origin.17 Though they
applied to white people and African›Americans, they
needed recalibration in other ethnic groups (Japanese,
Hispanic, and native Americans). Similarly, southern
European populations have a lower rate of CHD and
therefore the Framingham equations overestimate the
risk and the need for treatment.18 Our risk predictions
in white people in south London agree with other esti›
mates in similar UK samples.19–21 However, in south
Asians and especially in people of African origin the
use of risk of CHD underestimated their risk of CVD.
The joint British Societies2 and the BHS Guidelines3
recognise that the current guidelines may underesti›
mate the risk in ethnic minorities. They suggest that the
different distribution of risk factors in some communi›
ties may require a specific approach tailored to the dif›
ferent profiles of risk factors.2 Our study provides the
first quantitative estimate of this to guide clinical prac›
tice in the United Kingdom.
Implications
The application of the hypertension guidelines to
people with uncomplicated mild hypertension might
lead to undertreatment of people of south Asians and
African origin, who would not be considered for drug
therapy despite high risk of combined CVD. One alter›
native would be to calculate risk of CVD routinely
rather than risk of CHD in these groups and to treat
according to risk of CVD, as recently suggested by the
European SCORE (systematic coronary risk evalua›
tion) project. However, while some guidelines use the
risk of CVD,22 most calculators of risk and charts
currently in use in primary care in the United
Kingdom give risk of CHD. If general practitioners
continue to estimate CHD risk, then lower thresholds
(for example, 10% in people of African origin and 12%
in south Asians rather than 15%) may be more appro›
priate to guide management. This would considerably
increase the likelihood of being treated and would
include most of those with a risk of CVD >20%. A
reduction of the threshold of risk of CHD would also
lead to a small increase in the number of people with a
risk of CVD < 20% who would be offered antihyper›
tensive drugs. However, large intervention trials of
antihypertensive treatment suggest this is safe, and any
reduction in mildly raised blood pressure towards
target levels is likely to be associated with reduced
morbidity even in this low risk group.23
Detection, management, and control of hyper›
tension in the United Kingdom is currently inad›
equate,7 24 despite trends in improvement.25 Our study
suggests that the ethnic group with the greatest need
(people of African origin with higher prevalence of
hypertension, greater likelihood of treatment, but
worse blood pressure control) may continue to be
undertreated because risk of CHD is not an accurate
reflection of their risk of combined CVD. This is likely
to widen inequalities in management of hypertension
and prevention of cardiovascular disease. It may also
contribute to an ineffective and inadequate implemen›
tation of the National Service Framework for CHD in
primary care, particularly in inner cities, where the
representation of ethnic minority groups may be high.
In contrast better blood pressure control in all groups
would lead to a greater proportional reduction in
cardiovascular risk in people of south Asian and
African origin.
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